In the string of pension-plan related, actuarial equivalence lawsuits, the court in DeBuske, et al. v. PepsiCo, Inc., et al. recently handed down the first decision favorable to plan sponsors. The DeBuske court’s narrow decision may, however, have limited impact going forward.
Federal District Court Dismisses Pension Actuarial-Equivalence Lawsuit
By Lisa Loesel and Richard J. Pearl on October 17, 2019
Posted In Benefit Controversies, Retirement Plans
Lisa LoeselLisa Loesel focuses her practice on employee benefits matters, including the design, amendment and administration of pension and 401(k) plans, nonqualified deferred compensation arrangements, and employee stock ownership plans. She counsels privately and publicly held corporations regarding the employee benefits design and transition matters arising from corporate mergers, acquisitions and divestitures. She also advises clients regarding fiduciary and plan investment issues under the Employee Retirement Income Security Act of 1974 (ERISA). Lisa also has experience counseling plan fiduciaries with respect to the claims and appeals procedures under ERISA. Read Lisa Loesel's full bio.
Richard J. PearlRick Pearl focuses his practice on litigation involving the Employee Retirement Income Security Act of 1974 (ERISA). He represents companies, their benefits committees, plan administrators, fiduciaries, and service providers in complex, class-action litigation and Department of Labor lawsuits, audits, and investigations. His particular expertise is with actions for breach of fiduciary duty and prohibited transactions. Read Rick Pearl's full bio.
Related Posts
- COVID-19 Ate My Homework – Recent Extensions and Relief for Retirement Plans
- Ninth Circuit Considers Rehearing in ERISA Arbitration Case
- DOL Issues New Proposed Rule for Electronic Disclosures of Retirement Plan Notices
- Federal Court Certifies Class in Multiple-Plan ERISA Challenge to Health-Plan and Retirement-Plan Fees
- SECURE 2.0 Technical Corrections Are on the Way, Eventually
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- New EO Targets Prescription Drug Costs – and Drug Manufacturers, Hospitals, and Health Centers
- Understanding and Navigating Compliance With NIH Grant DEI Policies
- 5 Trends in Health Plan Regulations to Watch in New Trump Administration
- IRS Announces 2026 Limits for Health Savings Accounts, High-Deductible Health Plans, and Excepted Benefit HRAs
- DOJ Secures Its First-Ever Conviction in a Criminal Antitrust Labor Market Trial
